Peculiar pathological, radiological and clinical features of skull base dedifferentiated chordomas. Results from a referral Center case series and literature review

Sofia Asioli, Matteo Zoli, Federica Guaraldi, Giacomo Sollini, Antonella Bacci, Dino Gibertoni, Costantino Ricci, Luca Morandi, Ernesto Pasquini, Alberto Righi, Diego Mazzatenta

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Dedifferentiated chordoma is an uncommon and incompletely characterized aggressive neoplasm. Only few cases originating from the skull base have been reported.

MATERIAL & METHODS: All consecutive cases of skull base dedifferentiated chordomas treated surgically in a referral Center from January 1990 to June 2019 were retrospectively evaluated to assess peculiar pathological, radiological and clinical features. Patient data were retrieved from paper and electronic records.

RESULTS: Six cases (4 F; mean age at surgery 46 years, range 35-64), treated surgically at our Institution were identified. Transformation to dedifferentiated chordomas occurred after radiation therapy in 3 cases (mean 13.6 years after treatment, range 5-25), 2 during tumor progression, while one was de-novo. Magnetic resonance imaging and surgical examination revealed the presence of two different tumor components, corresponding to the conventional and dedifferentiated portion at histological examination. The de novo case presented a PIK3CA mutation. DNA methylation analysis revealed consistent epigenetic changes in TERT, MAGEA11 and UXT. Prognosis was poor as 5 out of 6 patients died after surgery and radiation therapy, with a mean overall survival of 29 months (range 11-52).

CONCLUSIONS: Skull base dedifferentiated chordomas are extremely rare and aggressive neoplasms with characteristic magnetic resonance imaging, surgical and histological features. Therefore, an early and accurate histological diagnosis is of paramount relevance. Molecular analysis appears promising to define mechanisms involved in tumor dedifferentiation.

Original languageEnglish
JournalHistopathology
DOIs
Publication statusE-pub ahead of print - Oct 25 2019

Fingerprint

Chordoma
Skull Base
Referral and Consultation
Neoplasms
Radiotherapy
Magnetic Resonance Imaging
DNA Methylation
Epigenomics
Mutation
Survival

Keywords

  • Dedifferentiated chordoma
  • bone tumor
  • endoscopic endonasal surgery
  • outcome
  • skull base tumor

Cite this

Peculiar pathological, radiological and clinical features of skull base dedifferentiated chordomas. Results from a referral Center case series and literature review. / Asioli, Sofia; Zoli, Matteo; Guaraldi, Federica; Sollini, Giacomo; Bacci, Antonella; Gibertoni, Dino; Ricci, Costantino; Morandi, Luca; Pasquini, Ernesto; Righi, Alberto; Mazzatenta, Diego.

In: Histopathology, 25.10.2019.

Research output: Contribution to journalArticle

@article{e7b4924f90344a9e8aecf03fe4aaaedb,
title = "Peculiar pathological, radiological and clinical features of skull base dedifferentiated chordomas. Results from a referral Center case series and literature review",
abstract = "BACKGROUND: Dedifferentiated chordoma is an uncommon and incompletely characterized aggressive neoplasm. Only few cases originating from the skull base have been reported.MATERIAL & METHODS: All consecutive cases of skull base dedifferentiated chordomas treated surgically in a referral Center from January 1990 to June 2019 were retrospectively evaluated to assess peculiar pathological, radiological and clinical features. Patient data were retrieved from paper and electronic records.RESULTS: Six cases (4 F; mean age at surgery 46 years, range 35-64), treated surgically at our Institution were identified. Transformation to dedifferentiated chordomas occurred after radiation therapy in 3 cases (mean 13.6 years after treatment, range 5-25), 2 during tumor progression, while one was de-novo. Magnetic resonance imaging and surgical examination revealed the presence of two different tumor components, corresponding to the conventional and dedifferentiated portion at histological examination. The de novo case presented a PIK3CA mutation. DNA methylation analysis revealed consistent epigenetic changes in TERT, MAGEA11 and UXT. Prognosis was poor as 5 out of 6 patients died after surgery and radiation therapy, with a mean overall survival of 29 months (range 11-52).CONCLUSIONS: Skull base dedifferentiated chordomas are extremely rare and aggressive neoplasms with characteristic magnetic resonance imaging, surgical and histological features. Therefore, an early and accurate histological diagnosis is of paramount relevance. Molecular analysis appears promising to define mechanisms involved in tumor dedifferentiation.",
keywords = "Dedifferentiated chordoma, bone tumor, endoscopic endonasal surgery, outcome, skull base tumor",
author = "Sofia Asioli and Matteo Zoli and Federica Guaraldi and Giacomo Sollini and Antonella Bacci and Dino Gibertoni and Costantino Ricci and Luca Morandi and Ernesto Pasquini and Alberto Righi and Diego Mazzatenta",
note = "{\circledC} 2019 John Wiley & Sons Ltd.",
year = "2019",
month = "10",
day = "25",
doi = "10.1111/his.14024",
language = "English",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Peculiar pathological, radiological and clinical features of skull base dedifferentiated chordomas. Results from a referral Center case series and literature review

AU - Asioli, Sofia

AU - Zoli, Matteo

AU - Guaraldi, Federica

AU - Sollini, Giacomo

AU - Bacci, Antonella

AU - Gibertoni, Dino

AU - Ricci, Costantino

AU - Morandi, Luca

AU - Pasquini, Ernesto

AU - Righi, Alberto

AU - Mazzatenta, Diego

N1 - © 2019 John Wiley & Sons Ltd.

PY - 2019/10/25

Y1 - 2019/10/25

N2 - BACKGROUND: Dedifferentiated chordoma is an uncommon and incompletely characterized aggressive neoplasm. Only few cases originating from the skull base have been reported.MATERIAL & METHODS: All consecutive cases of skull base dedifferentiated chordomas treated surgically in a referral Center from January 1990 to June 2019 were retrospectively evaluated to assess peculiar pathological, radiological and clinical features. Patient data were retrieved from paper and electronic records.RESULTS: Six cases (4 F; mean age at surgery 46 years, range 35-64), treated surgically at our Institution were identified. Transformation to dedifferentiated chordomas occurred after radiation therapy in 3 cases (mean 13.6 years after treatment, range 5-25), 2 during tumor progression, while one was de-novo. Magnetic resonance imaging and surgical examination revealed the presence of two different tumor components, corresponding to the conventional and dedifferentiated portion at histological examination. The de novo case presented a PIK3CA mutation. DNA methylation analysis revealed consistent epigenetic changes in TERT, MAGEA11 and UXT. Prognosis was poor as 5 out of 6 patients died after surgery and radiation therapy, with a mean overall survival of 29 months (range 11-52).CONCLUSIONS: Skull base dedifferentiated chordomas are extremely rare and aggressive neoplasms with characteristic magnetic resonance imaging, surgical and histological features. Therefore, an early and accurate histological diagnosis is of paramount relevance. Molecular analysis appears promising to define mechanisms involved in tumor dedifferentiation.

AB - BACKGROUND: Dedifferentiated chordoma is an uncommon and incompletely characterized aggressive neoplasm. Only few cases originating from the skull base have been reported.MATERIAL & METHODS: All consecutive cases of skull base dedifferentiated chordomas treated surgically in a referral Center from January 1990 to June 2019 were retrospectively evaluated to assess peculiar pathological, radiological and clinical features. Patient data were retrieved from paper and electronic records.RESULTS: Six cases (4 F; mean age at surgery 46 years, range 35-64), treated surgically at our Institution were identified. Transformation to dedifferentiated chordomas occurred after radiation therapy in 3 cases (mean 13.6 years after treatment, range 5-25), 2 during tumor progression, while one was de-novo. Magnetic resonance imaging and surgical examination revealed the presence of two different tumor components, corresponding to the conventional and dedifferentiated portion at histological examination. The de novo case presented a PIK3CA mutation. DNA methylation analysis revealed consistent epigenetic changes in TERT, MAGEA11 and UXT. Prognosis was poor as 5 out of 6 patients died after surgery and radiation therapy, with a mean overall survival of 29 months (range 11-52).CONCLUSIONS: Skull base dedifferentiated chordomas are extremely rare and aggressive neoplasms with characteristic magnetic resonance imaging, surgical and histological features. Therefore, an early and accurate histological diagnosis is of paramount relevance. Molecular analysis appears promising to define mechanisms involved in tumor dedifferentiation.

KW - Dedifferentiated chordoma

KW - bone tumor

KW - endoscopic endonasal surgery

KW - outcome

KW - skull base tumor

U2 - 10.1111/his.14024

DO - 10.1111/his.14024

M3 - Article

C2 - 31652338

JO - Histopathology

JF - Histopathology

SN - 0309-0167

ER -